Paroxetine (Paxil® and generic or Paxil CR® and generic) is a selective serotonin reuptake inhibitor. Here is key information about this medication.
Paroxetine
FDA-approved indications
Major Depressive Disorder
Obsessive-Compulsive Disorder
Panic Disorder
Social Anxiety Disorder
Generalized Anxiety Disorder
Post-Traumatic Stress Disorder
Dosage
Major Depressive Disorder
Initial: 20 mg/day (recommended), 50 mg/day (maximum)
Maintenance: Individualized as needed
Obsessive-Compulsive Disorder
Initial: 20 mg/day (starting), 40 mg/day (recommended), 60 mg/day (maximum)
Maintenance: Inividualized as needed
Panic Disorder
Initial: 10 mg/day (starting), 40 mg/day (recommended), 60 mg/day (maximum)
Maintenance: Inividualized as needed
Social Anxiety Disorder
Initial: 20 mg/day (starting), 20 mg/day (recommended), no evidence of benefit >20 mg/day
Maintenance: Inividualized as needed
Generalized Anxiety Disorder
Initial: 20 mg/day (starting), 20 mg/day (recommended), 50 mg/day (maximum), no evidence of benefit >20 mg/day
Maintenance: Inividualized as needed
Post-Traumatic Stress Disorder
Initial: 20 mg/day (starting), 20 mg/day (recommended), 50 mg/day (maximum), no evidence of benefit >20 mg/day
Maintenance: Inividualized as needed
General Instructions: Take once daily in the morning, with or without food.
Dosage forms and strengths (USA)
Tablets (Paxil® and generic): 10 mg scored, 20 mg scored, 30 mg, 40 mg
Oral Suspension (Paxil®): 10 mg/5 mL
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Paroxetine Controlled-Release (Paxil CR®)
Paroxetine controlled-release tablets contain a polymeric matrix designed to control the dissolution rate of paroxetine over a period of approximately 4 to 5 hours. In addition, an enteric coat delays the start of drug release until tablets have left the stomach.
FDA-approved indications
Major Depressive Disorder
Panic Disorder
Social Anxiety Disorder
Premenstrual Dysphoric Disorder
Dosage
Major Depressive Disorder
Initial: 25 mg/day (starting), 25 mg/day (recommended), 62.5 mg/day (maximum)
Maintenance: Individualized as needed
Panic Disorder
Initial: 12.5 mg/day (starting), 75 mg/day (maximum)
Maintenance: Individualized as needed
Social Anxiety Disorder
Initial: 12.5 mg/day (starting), 37.5 mg/day (maximum)
Maintenance: Individualized as needed
Premenstrual Dysphoric Disorder
Initial: 12.5 mg/day (starting), 25 mg/day (maximum)
Maintenance: No controlled trials beyond 3 menstrual cycles, individualized as needed
General Instructions: Take once daily in the morning, with or without food.
Dosage forms and strengths (USA)
Tablets (Paxil CR® and generic): 12.5 mg, 25 mg, 37.5 mg
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Related Pages
SSRI/ SNRI plus mirtazapine: What three clinical trials found
Cytochrome P450 and psychiatric medications
How and when to titrate up antidepressants
Common and important drug interactions
Antidepressants: Index and Links
References
Prescribing information for paroxetine (Paxil®)
Prescribing information for paroxetine controlled-release (Paxil CR®)
Copyright 2016, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave your comment or question about the content on this page